Special stem cells for bone

Mone Zaidi; Li Sun; Harry C. Blair

doi:10.1016/j.stem.2012.02.012

Special stem cells for bone

Mone Zaidi
, Li Sun
, Harry C. Blair

Research output: Contribution to journal › Short survey › peer-review

12 Scopus citations

Abstract

Mesenchymal stem cells (MSCs) are multipotential in vitro, but their endogenous properties are poorly defined. In this issue of Cell Stem Cell, Park et al. (2012) report that an MSC-like, osteolineage-directed Mx1+ population generates new osteoblasts at sites of bone damage, suggesting its potential for skeletal repair and regeneration.

Original language	English
Pages (from-to)	233-234
Number of pages	2
Journal	Cell Stem Cell
Volume	10
Issue number	3
DOIs	https://doi.org/10.1016/j.stem.2012.02.012
State	Published - 2 Mar 2012

Access to Document

10.1016/j.stem.2012.02.012

Cite this

@article{b74a347b1530438d96061bd914f04322,

title = "Special stem cells for bone",

abstract = "Mesenchymal stem cells (MSCs) are multipotential in vitro, but their endogenous properties are poorly defined. In this issue of Cell Stem Cell, Park et al. (2012) report that an MSC-like, osteolineage-directed Mx1+ population generates new osteoblasts at sites of bone damage, suggesting its potential for skeletal repair and regeneration.",

author = "Mone Zaidi and Li Sun and Blair, \{Harry C.\}",

note = "Funding Information: M.Z., S.L., and H.C.B. acknowledge support from the National Institutes of Health. M.Z. consults for Amgen and Questcor, and is a named inventor of a pending patent application related to osteoclastic bone resorption filed by the Mount Sinai School of Medicine (MSSM). In the event the pending or issued patent is licensed, he would be entitled to a share of any proceeds MSSM receives from the licensee.",

year = "2012",

month = mar,

day = "2",

doi = "10.1016/j.stem.2012.02.012",

language = "English",

volume = "10",

pages = "233--234",

journal = "Cell Stem Cell",

issn = "1934-5909",

publisher = "Cell Press",

number = "3",

}

TY - JOUR

T1 - Special stem cells for bone

AU - Zaidi, Mone

AU - Sun, Li

AU - Blair, Harry C.

N1 - Funding Information: M.Z., S.L., and H.C.B. acknowledge support from the National Institutes of Health. M.Z. consults for Amgen and Questcor, and is a named inventor of a pending patent application related to osteoclastic bone resorption filed by the Mount Sinai School of Medicine (MSSM). In the event the pending or issued patent is licensed, he would be entitled to a share of any proceeds MSSM receives from the licensee.

PY - 2012/3/2

Y1 - 2012/3/2

N2 - Mesenchymal stem cells (MSCs) are multipotential in vitro, but their endogenous properties are poorly defined. In this issue of Cell Stem Cell, Park et al. (2012) report that an MSC-like, osteolineage-directed Mx1+ population generates new osteoblasts at sites of bone damage, suggesting its potential for skeletal repair and regeneration.

AB - Mesenchymal stem cells (MSCs) are multipotential in vitro, but their endogenous properties are poorly defined. In this issue of Cell Stem Cell, Park et al. (2012) report that an MSC-like, osteolineage-directed Mx1+ population generates new osteoblasts at sites of bone damage, suggesting its potential for skeletal repair and regeneration.

UR - https://www.scopus.com/pages/publications/84857835052

U2 - 10.1016/j.stem.2012.02.012

DO - 10.1016/j.stem.2012.02.012

M3 - Short survey

AN - SCOPUS:84857835052

SN - 1934-5909

VL - 10

SP - 233

EP - 234

JO - Cell Stem Cell

JF - Cell Stem Cell

IS - 3

ER -

Special stem cells for bone

Abstract

Access to Document

Fingerprint

Cite this